Syngenta and Lavie Bio join forces on novel bioinsecticides
Switzerland-based Syngenta Crop Protection, and Israel’s Lavie Bio, an ag-biologicals company and a subsidiary of Evogene, announced an agreement for the discovery and development of new biological insecticidal solutions.
The collaboration will leverage Lavie Bio’s technology platform to rapidly identify bio-insecticide candidates, as well as Syngenta’s extensive global research, development and commercialisation capabilities.
“Syngenta is a leader in advancing sustainable agriculture and we are thrilled to collaborate with Lavie Bio in biocontrol innovation and bring novel modes of action in the growers’ toolbox to combat insect resistance,” said Camilla Corsi, Global Head of Research at Syngenta Crop Protection. “This collaboration underscores Syngenta’s commitment to collaborating with cutting-edge agricultural technology companies, merging digital and experimental approaches to accelerate and diversify innovation.”
“We’re excited to collaborate with Syngenta, a world leader in agricultural innovation,” said Amit Noam, CEO of Lavie Bio. “Both companies share a mutual commitment to sustainable farming, and together, we aim to develop an impactful bio-insecticide product. Lavie Bio’s unique computational capabilities and Syngenta’s vast experience in developing and commercializing innovative products make this partnership significant. We enthusiastically look forward to joining forces to achieve the mutual task of insect management in agriculture.”
Image: Getty/SilviaJansen
